Effectiveness of intravenous Augmentin in the treatment of thalassaemic patients with Yersinia enterocolitica infection.
Four thalassaemic patients with severe Yersinia enterocolitica infection were treated effectively with Augmentin. In three patients initial treatment with ampicillin and gentamicin was not effective. Augmentin was well tolerated and no toxic effects were detected on biochemical and haematological follow-up.
D000658:Amoxicillin / Q000627:therapeutic use*; D019980:Amoxicillin-Potassium Clavulanate Combination; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002969:Clavulanic Acids / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D013789:Thalassemia / Q000150:complications*; D015009:Yersinia Infections / Q000150:complications / Q000188:drug therapy*; D015008:Yersinia enterocolitica
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D004338:Drug Combinations; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin